Diagnostics refers to the practice of conducting multiple tests to detect disease or health condition of a person. Diagnosis helps identify a disease accurately when there are symptoms to screen asymptomatic patients as a matter of routine and to allow an ongoing testing process for patients to establish prognosis or check the progress of therapy. Diagnostic tests are usually done in laboratories, private or public, equipped with appropriate and sometimes expensive instrumentation.

Molecular diagnostic tests combine genetic sequencing, clinical information, and data gathering to help oncologists select the right drug for patients based on mutations in various cancer-related genes. Moreover, diagnostics is applied in the field of epigenetics for the formulation of different personalized medicines. Companion diagnostics is expected to embrace a vital role in the future for new drugs in specialty markets. Hence, diagnostics providers are actively expanding into markets in developing countries, where there is an increasing demand for quality healthcare services. However, stable in-vitro diagnostics market growth is also expected in developed countries.

Diagnostics has its foothold in various fields:

  • Improves patient care
  • Protects consumer safety
  • Reduces the risk of trial-and-error treatment and over-prescription
  • Shortens the duration of pre-treatment/decreases the duration of hospital stay

Our analysts are specialized in a wide range of diagnostics, including molecular assays, infectious disease, POC, hematology, immunoassays, and oncology.

Need any assistance on the diagnostics market? Please get in touch with our experts!